Clinical trials
Completed Isolated Systolic Hypertension trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2006 | 2 |
| 2009 | 1 |
| 2011 | 2 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| CAMC Health System | 1 |
| Daiichi Sankyo | 1 |
| Novartis | 1 |
| Synvista Therapeutics, Inc | 1 |
| UConn Health | 1 |
| University of Iowa | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Isolated Systolic Hypertension | 8 |
| Hypertension | 4 |
| Cardiovascular Diseases | 2 |
| Cerebrovascular Disorders | 1 |
| Heart Failure | 1 |
| Hypertriglyceridemia | 1 |
| Insulin Resistance | 1 |
| Metabolic Syndrome | 1 |
| Obesity, Abdominal | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.